Adverse effects of the contraceptive implant in family planning users of the Pampa Grande 2023 health center

Abstract

Introduction: The global use of the etonogestrel subdermal implant has increased, being distributed free of charge in our country. However, local information is required on its adverse effects, which influence abandonment of the method, to address social and cultural aspects of birth control interventions. Objective: To describe the adverse effects
of the contraceptive implant in family planning users of the Pampa Grande health center, 2023. Methods: This is non-experimental quantitative research, with a simple cross-sectional descriptive design. A proprietary questionnaire was used to evaluate the adverse effects in 45 users of the contraceptive implant at the Pampa Grande health center. Results: The results reveal that a third (33.3%) of implant users experience the suspension of menstruation, especially in the age range of 23 to 27 years, while another third (33.3%) in the same age group, perceives your cycle as normal. Among those with menstrual cessation, 53.3% have completed secondary education, and 55.6% of that group report that their cycle does not follow a monthly pattern. Furthermore, 77.8% experience menstrual
cessation after 1 to 5 years of use, and within this period, 84.4% describe their cycle as irregular. Conclusion: Thus, concluding that the predominant adverse reactions are the suspension of menstruation in 84.4% and the alteration of the menstrual cycle in 91.1%.